Stock Traders Purchase High Volume of Agilent Technologies Call Options (A)

Agilent Technologies, Inc. (NYSE:A) saw some unusual options trading activity on Thursday. Stock investors bought 3,142 call options on the stock. This represents an increase of Infinity compared to the typical daily volume of 0 call options.

In other Agilent Technologies news, insider Dominique Grau sold 13,007 shares of the company’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $62.00, for a total value of $806,434.00. Following the transaction, the insider now directly owns 60,098 shares in the company, valued at approximately $3,726,076. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mark Doak sold 12,421 shares of the company’s stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $61.57, for a total transaction of $764,760.97. The disclosure for this sale can be found here. Insiders have sold a total of 165,720 shares of company stock worth $10,488,739 over the last quarter.

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Advisor Group Inc. raised its holdings in shares of Agilent Technologies by 0.3% in the second quarter. Advisor Group Inc. now owns 3,959 shares of the medical research company’s stock worth $235,000 after buying an additional 10 shares during the last quarter. Bronfman E.L. Rothschild L.P. raised its holdings in shares of Agilent Technologies by 0.8% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 4,658 shares of the medical research company’s stock worth $276,000 after buying an additional 35 shares during the last quarter. Veritable L.P. raised its holdings in shares of Agilent Technologies by 0.4% in the second quarter. Veritable L.P. now owns 10,896 shares of the medical research company’s stock worth $646,000 after buying an additional 40 shares during the last quarter. Trust Co. of Vermont raised its holdings in shares of Agilent Technologies by 1.8% in the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock worth $166,000 after buying an additional 50 shares during the last quarter. Finally, Balentine LLC raised its holdings in shares of Agilent Technologies by 2.9% in the second quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after buying an additional 50 shares during the last quarter.

A number of equities analysts have commented on A shares. Jefferies Group LLC restated a “buy” rating and issued a $66.00 target price on shares of Agilent Technologies in a research note on Wednesday, August 9th. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 target price on the stock in a research note on Tuesday, October 31st. Robert W. Baird restated a “buy” rating and issued a $70.00 target price on shares of Agilent Technologies in a research note on Friday, October 20th. Barclays PLC restated a “buy” rating and issued a $67.00 target price on shares of Agilent Technologies in a research note on Wednesday, July 19th. Finally, Janney Montgomery Scott upped their price target on shares of Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a research report on Wednesday, August 16th. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Agilent Technologies has a consensus rating of “Buy” and a consensus price target of $66.70.

Shares of Agilent Technologies (NYSE A) opened at $66.81 on Friday. Agilent Technologies has a 52-week low of $42.92 and a 52-week high of $68.67. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.76 and a current ratio of 3.22. The company has a market cap of $21,713.74, a P/E ratio of 29.46, a P/E/G ratio of 2.65 and a beta of 1.27.

Agilent Technologies (NYSE:A) last posted its earnings results on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.07. The company had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. Agilent Technologies’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.49 earnings per share. equities analysts forecast that Agilent Technologies will post 2.32 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 25th. Shareholders of record on Tuesday, October 3rd were issued a $0.132 dividend. The ex-dividend date of this dividend was Monday, October 2nd. This represents a $0.53 dividend on an annualized basis and a dividend yield of 0.79%. Agilent Technologies’s dividend payout ratio is currently 27.32%.

ILLEGAL ACTIVITY NOTICE: This piece was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.dispatchtribunal.com/2017/11/12/stock-traders-purchase-high-volume-of-agilent-technologies-call-options-a.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply